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Hand Eczema Is Common and 
Multifactorial
Pieter-Jan Coenraads1
Clinicians agree that hand eczema is multifactorial, although there are many 
uncertainties regarding causative factors. Atopic dermatitis is assumed to be 
a major risk factor, whereas the role of allergies is overestimated. Twin studies 
may shed light on the contribution of other endogenous, possibly genetic fac-
tors versus the role of exposure to environmental agents, with the latter being 
amenable to prevention and intervention.
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The term “hand eczema” implies an 
inflammation of the skin (dermati-
tis) that is confined to the hands. It is 
a common condition, with a point 
prevalence of 1–5% among adults in 
the general population and a 1-year 
prevalence of up to 10%, although 
these high estimates may be based on 
inclusion of mild cases. Based on a 
retrospective questionnaire study, the 
annual incidence is estimated at 5 per 
1,000 (Meding and Jarvholm, 2004). 
The incidence of notified (i.e., usu-
ally more severe) occupation-related 
cases is estimated to be above 0.7 
workers per 1,000 per year (Diepgen, 
2003). A high prevalence has been 
documented in specific occupational 
groups, such as nurses, hairdressers, 
and bakers. These estimates exclude 
people affected through housework 
and many other occupational groups 
not included in routine surveillance 
systems. A decreased prevalence has 
been observed in Swedish adults; it is 
attributed to decreased occupational 
exposure to irritants. Hand eczema is 
twice as common in women as in men, 
with the highest prevalence in young 
women. Although genetic factors have 
been considered a reason for this dif-
ference, greater exposure of women 
to wet work is assumed to be the most 
likely explanation. Hand eczema has 
a considerable public health impact 
because it tends to run a chronic 
relapsing course, with the vast majority 
of patients experiencing negative psy-
chosocial consequences. Epidemiology 
is helpful in trying to understand hand 
eczema and in dispelling myths about 
the role of allergy.
Do we know the cause?
Predisposing endogenous and exter-
nal factors both play a part in hand 
eczema. Being atopic (commonly, but 
not precisely defined as having a ten-
dency to develop asthma, hay fever, 
or eczema) is assumed to be related to 
the risk of developing and maintain-
ing hand eczema; one third to one half 
of patients with hand eczema can be 
considered atopic (Svensson, 1988). 
Contrary to atopic dermatitis, respira-
tory atopy is at best only weakly asso-
ciated with hand eczema, and the 
association exists mainly because there 
is partial overlap of respiratory atopy 
with atopic dermatitis. It is becoming 
clear that atopy is not the main issue in 
atopic dermatitis. The role of atopy—
i.e., a state of having allergen-specific 
IgE reactivity toward environmental, 
mostly respiratory, agents—is chal-
lenged in “atopic” dermatitis (Flohr et 
al., 2004); most patients who have the 
clinical appearance of atopic dermati-
tis do not have a raised level of aller-
gen-specific IgE.
Although the heritability of atopic 
dermatitis is obvious, and several chro-
mosomal regions have been linked to 
it, there is now evidence that genetic 
factors unrelated to atopy (defined as 
an innate propensity to develop aller-
gen-specific IgE) may play a role in a 
subset of patients. A recent study dem-
onstrated a link with mutations in the 
filaggrin gene, leading to structural 
defects in the skin-barrier region (Irvine 
and McLean, 2006). Because the hands 
take most of the burden of exposure to 
environmental agents, it is quite pos-
sible that this defect plays a role in a 
number of patients whose hand eczema 
has been labeled atopic (palmoplantar) 
dermatitis. Studies on the water barrier 
of the skin, using transepidermal water 
loss measurements, have failed to dem-
onstrate that impaired water barrier in 
unexposed skin is a good predictor of 
irritant contact dermatitis (Smit et al., 
1994), although the studies may have 
lacked power when adjusting for atop-
ic dermatitis. Skin penetration of cer-
tain chemicals is increased in atopic 
dermatitis (McLean and Hull, 2007).
The most common external cause of 
hand eczema is contact with irritants, 
or mild toxic agents; water or soaps are 
typical examples of a contact irritant. 
A distinction is made between irritant 
contact dermatitis and allergic contact 
dermatitis. Allergic contact dermatitis 
of the hands is much less common than 
irritant contact dermatitis and occurs 
only in people who have developed a 
contact allergy to a specific substance, 
such as rubber chemicals, nickel, or 
biocides. Theoretically, identifying and 
eliminating an allergic contact factor 
(e.g., allergy to rubber components) 
could cure hand eczema if this is the 
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sole cause. In clinical practice, such 
cases are rare, because hand eczema is 
often due to a combination of endoge-
nous factors and irritant and allergic 
contact factors. Atopic individuals are 
not more prone to (T-cell-mediated) 
contact allergy. Nickel allergy is com-
mon in hand eczema, but its role as a 
causative or sustaining agent is chal-
lenged. To complicate things, it is pos-
sible that atopic dermatitis, especially 
the accompanying skin-barrier impair-
ment, is an effect modifier of the expo-
sure to irritants.
Genes or environment?
In this issue of the Journal of 
Investigative Dermatology a quantita-
tive genetic epidemiologic study on 
hand eczema in monozygotic ver-
sus dizygotic twins by Lerbaek et al. 
(2007, this issue) gives a closer look 
at the relative contribution of environ-
mental and genetic factors, while con-
trolling for atopic dermatitis (of which 
the genetic control is obvious). By 
analysis of the variance of the correla-
tion coefficients in monozygotic and 
dizygotic twins, the authors demon-
strated that, after controlling for atopic 
dermatitis, 59% of hand eczema could 
be attributed to environmental factors. 
The role of genetic factors in contact 
allergy to nickel, based on twins with 
hand eczema, was discussed in an 
earlier article in the JID by the same 
group, and they concluded that nickel 
allergy was unlikely to have a genetic 
basis (Bryld et al., 2004). The pres-
ent study supported these findings by 
demonstrating that having been diag-
nosed with contact allergy (a positive 
patch test) had a negligible impact on 
the role of genetic factors. The study 
was unable to address the issue of 
gene–environment interactions; such 
interactions may imply that the same 
exposure has different effects on differ-
ent genotypes of hand eczema, if such 
genotypes exist.
The study was entirely question-
naire-based. To study the role of atopic 
dermatitis the investigators based them-
selves on self-reported clinical mani-
festations of eczema. In Scandinavia, 
questionnaires on eczema seem to 
have a reasonable sensitivity and a 
high specificity. The advantage is that 
this approach may avoid the pitfall of 
attributing a role to atopy (defined as a 
specific manifestation of IgE-mediated 
allergy) and that it includes the atopic 
dermatitis cases without allergen-spe-
cific IgE.
One of the problems that Lerbaek 
et al. (2007) encountered is that there 
are several not precisely defined types 
of hand eczema. Irritant contact der-
matitis, for example, is supposed to 
be common, but its diagnosis is based 
on nothing more than the absence of 
a positive patch test and a history of 
exposure to irritants. In addition, there 
are several types of hand eczema with 
a distinctive appearance of which the 
cause is unknown. These types may be 
referred to as pompholyx, dyshidrotic 
eczema or dyshidrosis, nummular 
eczema, tylotic eczema, and hyper-
keratotic eczema (the latter is often dif-
ficult to distinguish from psoriasis). It 
is possible that these types tend to be 
overrepresented among patients with a 
chronic, debilitating course. For a rare 
form of autosomal dominant pompho-
lyx, a locus on chromosome 18 has 
been identified (Chen et al., 2006).
Compared with family studies, twin 
studies are very helpful in separating 
environmental influence from genetic 
factors. The results are primarily attribu-
table to twins, and to be representative 
for the general population the method 
of recruiting twins is essential. Lerbaek 
et al. (2007) base their findings on 
62% of twin pairs who were born in 
a large region of Denmark. There may 
be some bias because there was an 
overrepresentation of females, while 
younger twins were underrepresented. 
Because the questionnaire focused 
on hand eczema, it is possible, as the 
authors acknowledge, that twins with 
this disease were overrepresented, 
inflating the prevalence estimates for 
the general population: their 1-year 
prevalence was almost 12%, with a 
point prevalence of almost 6%. An 
interesting observation was that high-
risk occupations and their accompa-
nying exposure had a higher concor-
dance in monozygotic twins. It is not 
unusual for monozygotic twins to have 
similarities in lifestyle, with similari-
ties in environmental and occupation-
al exposure, and this may influence 
the estimate of a hypothetical genetic 
impact.
Relevance to public health
In many patients with chronic hand 
eczema a combination of the factors 
mentioned above seems to play a role. 
This has led to the use of many diverse 
therapies and other intervention strate-
gies to control the disease. Protocols for 
ongoing systematic reviews of the evi-
dence for these treatments are acces-
sible in the database of the Cochrane 
Skin Group (http://www.nottingham.
ac.uk/~muzd/about/about.htm).
The hands are important organs 
of communication and expression. 
Therefore, any visible skin disease on 
the hands may result in major psy-
chosocial problems, e.g., anxiety, low 
self-esteem, and social phobia. Itch, 
fissures, and blisters, in addition to 
their effect on daily life outside work, 
can prevent manual work, leading to 
significant disability and economic 
loss to both individuals and society. 
Quality-of-life instruments only indi-
rectly address the impact on employ-
ment. A comparison of physician-rated 
assessments of severity with patient-
rated ones demonstrated a poor cor-
relation, indicating that patients value 
several aspects of their hand eczema 
differently than physicians.
For clinicians, the diagnosis and 
treatment of hand eczema is often a 
calculated guess. The study by Lerbaek 
et al. (2007) demonstrates the impor-
tance of environment and the moder-
ate impact of genetic factors on hand 
eczema, controlling for atopic derma-
titis, which is, at least partially, geneti-
cally based. The study calls for a more 
precise disease definition, including its 
subtypes and the types that are more 
likely to have a genetic basis. The 
environmental component of hand 
eczema is amenable to intervention. 
Even if genetically based diminished 
impairment of the barrier function is 
an important factor, the accompany-
ing increased susceptibility to envi-
ronmental agents calls for adequate 
preventive measures. Chronic hand 
eczema, whether regarded as a single 
entity or as a manifestation of differ-
ent diseases, remains a challenge to 
researchers and caregivers.
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Casting Light on Evidence
Jonathan L. Rees1
Clinicians are growing inured to the fact that rarely do the results of a single 
randomized controlled trial (RCT) decisively change clinical practice. Nor 
should they. In a new RCT, Kirke and colleagues have compared the therapeu-
tic effects of different types of UVB radiation on clearance of psoriasis. Their 
study is unlikely to be the last word on this topic.
Journal of Investigative Dermatology (2007) 127, 1570–1571. doi:10.1038/sj.jid.5700775
1Department of Dermatology, University of Edinburgh, Edinburgh, United Kingdom
Correspondence: Prof. Jonathan L. Rees, Department of Dermatology, University of Edinburgh, 
Room 4.018, First Floor, Lauriston Building, Lauriston Place, Edinburgh EH3 9HA, United Kingdom. 
E-mail: jonathan.rees@ed.ac.uk
CONFLICT OF INTEREST
The author states no conflict of interest.
REFERENCE
Bryld LE, Hindsbergen C, Kyvik KO, Agner T, 
Menne T (2004) Genetic factors in nickel 
allergy evaluated in a population-based 
female twin sample. J Invest Dermatol 
123:1025–9
Chen JJ, Liang YH, Zhou FS, Yang S, Wang J, 
Wang PG, et al. (2006) The gene for a rare 
autosomal dominant form of pompholyx 
maps to chromosome 18q22.1–18q22.3. 
J Invest Dermatol 126:300–4
Diepgen TL (2003) Occupational skin disease 
data in Europe. Int Arch Occup Environ 
Health 76:331–8
Flohr C, Johansson SG, Wahlgren CF, Williams 
HC (2004) How atopic is atopic dermatitis? 
J Allergy Clin Immunol 114:150–8
Irvine AD, McLean WHI (2006) Breaking the 
(un)sound barrier: filaggrin is a major gene 
for atopic dermatitis. J Invest Dermatol 
126:1200–2
Lerbaek A, Kyvik KO, Mortensen J, Bryld LE, 
Menné T, Agner T (2007) Heritability of hand 
eczema is not explained by comorbidity 
with atopic dermatitis. J Invest Dermatol 
127:1632–40
McLean WHI, Hull PR (2007) Breach delivery: 
increased solute uptake points to a defective 
barrier in atopic dermatitis. J Invest Dermatol 
127:8–10
Meding B, Jarvholm B (2004) Incidence of hand 
eczema-a population-based retrospective 
study. J Invest Dermatol 122:873–7
Smit HA, van Rijssen A, Vandenbroucke J, 
Coenraads PJ (1994) Individual susceptibility 
and the incidence of hand dermatitis in a 
cohort of apprentice hairdressers and nurses. 
Scand J Work Environ Health 20:113–21
Svensson A (1988) Hand eczema: an evaluation 
of the frequency of atopic background and the 
difference in clinical pattern between patients 
with and without atopic dermatitis. Acta Derm 
Venereol 68:509–13
Not long ago, in an age of optimism 
(and statistical naiveté), it seemed that 
you could read the results of a ran-
domized controlled trial (RCT) at the 
weekend and change your prescribing 
habits accordingly on Monday morn-
ing. It was as though the RCT was 
a truth machine: you just fed in the 
patients’ details, added a little random-
ization, mechanically applied some 
statistical test, and out popped a God’s-
eye view of how the Universe worked. 
A veritable epistemological engine. 
Things do not seem quite so simple 
anymore. Indeed, in a recent article, 
Ioannidis (2005) argued cogently, if a 
little mischievously, that the results of 
most clinical studies, including RCTs, 
were mistaken. With this in mind, 
what are we to make of the report by 
Kirke et al. (2007, this issue) that there 
is no difference in efficacy between 
narrowband phototherapy and (selec-
tive) broadband UVB lamps for the 
treatment of psoriasis? Should those 
recently purchased narrowband cabi-
nets be put to one side?
The use of UVB phototherapy to 
treat psoriasis has a long history, but 
it is probably only since the introduc-
tion of psoralen plus UVA (PUVA) 
that interest has focused on how this 
older modality of therapy could be 
made more efficacious. Subsequent 
clinical application has owed more 
to incremental improvement than to 
any “eureka” moments. However, 
if there was an elegant experiment, 
rather than the brute force of clinical 
trials, it was that reported by Parrish 
and Jaenicke in this journal in 1981 
(Parrish and Jaenicke, 1981). In this 
study, Parrish and Jaenicke exposed 
psoriatic plaques to monochromatic 
sources and showed that wavelengths 
less than 290 nm were erythemogen-
ic but had little efficacy. The implica-
tion was that it would be better to use 
lamps of longer wavelengths with the 
UVC filtered out. Although the exact 
relative efficacy of different longer 
UVB wavelengths was unclear, the 
invention of the 311 nm (Philips TL-
01) lamp soon led to their widespread 
use, at least in Europe. In a pattern 
common to the way many medical 
innovations are adopted, an appar-
ent physiological rationale, coupled 
with a few initial small-scale reports 
and enthusiasm by early adopters, 
led to widespread changes in clinical 
practice. Which is where the exem-
plary study by Kirke et al. (2007) 
comes into play. Is there anything spe-
cial about TL-01, or is it just that UVB 
lamps contaminated with UVC are 
less efficacious?
Kirke and colleagues (2007) 
screened 192 subjects in a single uni-
versity hospital center, of whom 124 
were eligible and 24 declined to par-
ticipate. The remaining 100 were ran-
domized, 50 in each group, to receive 
either TL-01 or (selective) UVB with 
UV6 fluorescent lamps. (UV6 bulbs 
have negligible output in the UVC 
range; see Kirke et al. (2007) for a 
comparison of the spectra of the two 
tube types.) The primary outcome was 
the number of treatments to clearance, 
and the proportion of patients clearing 
was also reported. The median num-
ber of exposures was 28.4 for TL-01 
and 30.4 for UV6. With TL-01, 56% of 
patients cleared, whereas with UV6, 
40% cleared. Neither of these com-
parisons was significant at the con-
ventional statistical level. So, in the 
light of the general claims by Ioannidis 
(2005), how do we interpret the data 
from this study as evidence? What 
does it mean?
